| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/27/2013 | US8518963 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers |
| 08/27/2013 | US8518962 Use of opioid antagonists |
| 08/27/2013 | US8518961 spontaneously dispersible; 7-t-butoxyiminomethylcamptothecin in microemulsion preconcentrate; topoisomerase I inhibitor; proliferative diseases including cancer; stability; bioavailability |
| 08/27/2013 | US8518960 Antiviral drugs for treatment or prevention of dengue infection |
| 08/27/2013 | US8518959 Quinoxaline derivatives as antitumor agents |
| 08/27/2013 | US8518958 Pyrido [2,3-D] pyrimidines and their use as kinase inhibitors |
| 08/27/2013 | US8518957 Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure |
| 08/27/2013 | US8518956 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl) piperidine-4-carboxylic acid and salts thereof |
| 08/27/2013 | US8518955 Fused pyrimidineone compounds as TRPV3 modulators |
| 08/27/2013 | US8518954 Inhibitors of folic acid-dependent enzymes |
| 08/27/2013 | US8518953 Aminopyrimidines useful as inhibitors of protein kinases |
| 08/27/2013 | US8518952 6 substituted 2-heterocyclylamino pyrazine compounds as CHK-1 inhibitors |
| 08/27/2013 | US8518951 Anti-arenaviral compounds |
| 08/27/2013 | US8518950 2-amido pyrazines for inflammation and immune related uses |
| 08/27/2013 | US8518949 Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| 08/27/2013 | US8518948 Inhibitors of protein kinases |
| 08/27/2013 | US8518947 (Heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors |
| 08/27/2013 | US8518946 Salts of (R)-7-[3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-trifluoromethyl-5,6,7,8-tetrahydroimidazo[1,5-a] pyrazine-1-carboxylic acid, preparation method and medical use thereof |
| 08/27/2013 | US8518945 Pyrrolopyrazine kinase inhibitors |
| 08/27/2013 | US8518944 Compounds as casein kinase inhibitors |
| 08/27/2013 | US8518943 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/27/2013 | US8518942 Caspase inhibitors and uses thereof |
| 08/27/2013 | US8518941 Extreme temperature aqueous decontamination composition |
| 08/27/2013 | US8518940 FP-pocket-binding effectors and methods for using the same to modulate telomerase activity |
| 08/27/2013 | US8518939 6-pyrimidinyl-pyrimid-4-one derivative |
| 08/27/2013 | US8518938 c-MET protein kinase inhibitors |
| 08/27/2013 | US8518937 Pyrimidinediamine kinase inhibitors |
| 08/27/2013 | US8518936 Method for preparing acid addition salts of polyacidic basic compounds |
| 08/27/2013 | US8518935 Amorphous besifloxacin solid |
| 08/27/2013 | US8518933 Modulators of 5-HT receptors and methods of use thereof |
| 08/27/2013 | US8518932 Oxime azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| 08/27/2013 | US8518931 Compounds and compositions as kinase inhibitors |
| 08/27/2013 | US8518930 Therapeutic combination comprising a CDKS inhibitor and an antineoplastic agent |
| 08/27/2013 | US8518929 Methods of treating hypertriglyceridemia |
| 08/27/2013 | US8518928 Therapeutic compounds |
| 08/27/2013 | US8518927 Chemically programmed vaccination |
| 08/27/2013 | US8518926 Compositions and methods of using (R)-pramipexole |
| 08/27/2013 | US8518925 Opioids for the treatment of the chronic obstructive pulmonary disease (COPD) |
| 08/27/2013 | US8518924 Agent for inhibiting visceral fat accumulation |
| 08/27/2013 | US8518923 Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation |
| 08/27/2013 | US8518922 Pharmaceutical solid state forms |
| 08/27/2013 | US8518921 Compositions and methods for inducing bone growth and inhibiting bone loss |
| 08/27/2013 | US8518920 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology |
| 08/27/2013 | US8518919 Compositions comprising azelastine and methods of use thereof |
| 08/27/2013 | US8518918 Combination of anticholinergics, β2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases |
| 08/27/2013 | US8518917 2-methylene-19-nor-vitamin D analogs and their uses |
| 08/27/2013 | US8518916 Heterocyclic derivatives as M-GLU5 antagonists |
| 08/27/2013 | US8518915 Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases |
| 08/27/2013 | US8518914 HMG-CoA reductase and farnesyl-pyrophosphate synthase inhibitors for the treatment of conditions related to prenylated proteins in cells |
| 08/27/2013 | US8518913 Phosphorous derivatives as chemokine receptor modulators |
| 08/27/2013 | US8518912 Phosphonic acid derivates and their use as P2Y12 receptor antagonists |
| 08/27/2013 | US8518911 Pyrazolo[1,5-a]pyridines as MARK inhibitors |
| 08/27/2013 | US8518910 Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety |
| 08/27/2013 | US8518909 Sulfated heptasaccharide and its use as an antithrombotic agent |
| 08/27/2013 | US8518908 Nucleobase-functionalized conformationally restricted nucleotides and oligonucleotides for targeting of nucleic acids |
| 08/27/2013 | US8518905 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment of prevention of toll-like receptor-4-associated disorders |
| 08/27/2013 | US8518903 Use of toll-like receptor-9 agonists |
| 08/27/2013 | US8518902 Use of RNAi technology to inhibit ASIC3 |
| 08/27/2013 | US8518901 Fused diimidazodiazepine compounds and methods of use and manufacture thereof |
| 08/27/2013 | US8518900 Macrolide synthesis process and solid-state forms |
| 08/27/2013 | US8518899 Macrocyclic polymorphs, compositions comprising such polymorphs and methods of use and manufacture thereof |
| 08/27/2013 | US8518898 Cytoprotective composition comprising hesperidin or pharmaceutically acceptable salt thereof as an active ingredient |
| 08/27/2013 | US8518897 Method of treatment for cancers associated with elevated HER2 levels |
| 08/27/2013 | US8518896 Treatment of cancers of the blood using selected glycomimetic compounds |
| 08/27/2013 | US8518895 Method for treating hyponatremia employing an SGLT2 inhibitor and composition containing same |
| 08/27/2013 | US8518891 Chemotherapeutic conjugates and methods of use |
| 08/27/2013 | US8518890 Luteinizing hormone-releasing hormone receptor agonist leuprorelin, or antagonist with androgen receptor agonist for prophylaxis, treatment of prostate cancer; dehydroepiandrosterone, testosterone, dihydrotestosterone; non-steroidal androgen receptor agonist; estradiol, estrone, estriol, stilbestrol |
| 08/27/2013 | US8518882 Administering choline cytidine 5-pyrophosphate which raises levels of uridine or uridine phosphate; improving memory, learning, cognition, synaptic transmission, synthesis/release of neurotransmitters, and increasing brain phospholipid levels; Alzheimer's disease |
| 08/27/2013 | US8518873 Method of inhibiting clostridium difficile by administration of oritavancin |
| 08/27/2013 | US8518869 Pharmaceutical combined preparation containing a therapeutic protein |
| 08/27/2013 | US8518694 Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV |
| 08/27/2013 | US8518460 Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis |
| 08/27/2013 | US8518451 Thyroid hormone analogs and methods of use |
| 08/27/2013 | US8518450 Nanoparticle carriers for drug administration and process for producing same |
| 08/27/2013 | US8518443 Opioid agonist formulations with releasable and sequestered antagonist |
| 08/27/2013 | US8518442 Prolonged release bioadhesive therapeutic systems |
| 08/27/2013 | US8518441 Solid dispersions or solid dispersion pharmaceutical preparations of phenylalanine derivatives |
| 08/27/2013 | US8518440 Biodegradable osmotic pump implant for drug delivery |
| 08/27/2013 | US8518439 Liquid therapeutic composition |
| 08/27/2013 | US8518437 Lipid carrier compositions with enhanced blood stability |
| 08/27/2013 | US8518434 Antiseptic spermicidal composition and means for its application |
| 08/27/2013 | US8518424 Resin powder for dermatologic composition, skin cleansing agent and cosmetic composition using the powder, and preparation processes of the powder |
| 08/27/2013 | US8518422 Cosmetic or dermatological preparation comprising a nutrient medium phase |
| 08/27/2013 | US8518421 Flashmelt oral dosage formulation |
| 08/27/2013 | US8518388 Cyclodextrin-based polymers for therapeutics delivery |
| 08/27/2013 | US8518379 Oral compositions for absorption of phosphorous compounds |
| 08/27/2013 | US8518376 Oil-based foamable carriers and formulations |
| 08/27/2013 | US8518375 Anti-viral tissue product with visual efficacy indicator |
| 08/27/2013 | US8517975 Device and method for producing therapeutic foam |
| 08/27/2013 | CA2777473C Compounds and methods for the treatment of cancer |
| 08/27/2013 | CA2754998C Substituted nicotinamides as kcnq2/3 modulators |
| 08/27/2013 | CA2731215C Imidazole carboxamide derivatives and their use in treatment of conditions associated with the mglur2 receptor |
| 08/27/2013 | CA2678754C Process for the preparation and purification of thiol-containing maytansinoids |
| 08/27/2013 | CA2678722C Antihypertensive combination of valsartan and a calcium channel blocker |
| 08/27/2013 | CA2659914C Antioxidant for preventing and treating diseases caused by oxidative stress |
| 08/27/2013 | CA2657776C Triazolyl phenyl benzenesulfonamides |
| 08/27/2013 | CA2649741C Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 08/27/2013 | CA2615053C Pharmaceutical formulations of endo-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1h-indazole-3-carboxamide hydrochloride |
| 08/27/2013 | CA2611902C Tiotropium salts, compositions thereof, and processes for preparing same via tiotropium bicarbonate reacted with an acid |
| 08/27/2013 | CA2606602C Pharmaceutical compositions comprising imatinib and a release retardant |